A clinical trial titled "Effectiveness of Entresto (Sacubitril/Valsartan) in Japanese Patients With Hypertension" has been updated to a status of completed, as recorded on August 14, 2026. The study is registered under the identifier NCT06604897. No phase was listed for this trial in the available record.
This update relates to the study status only and does not include any reported results, findings, or outcome data. The trial record does not specify efficacy or safety conclusions at this time. Readers should note that a completed status indicates the study has finished according to its registered timeline, not that results have been published or reviewed.
This trial update involves angiotensin II related pathways given the mechanism of sacubitril/valsartan, which is an approved therapy. The event data provided does not include additional detail on trial design, enrollment, or endpoints beyond the title and status change.
For further context on angiotensin II as a compound, readers can consult the compound overview page.